Literature DB >> 11982718

Role of hepatitis C virus in the development of hepatocellular carcinoma: transgenic approach to viral hepatocarcinogenesis.

Kazuhiko Koike1, Kyoji Moriya, Satoshi Kimura.   

Abstract

Overwhelming lines of epidemiologic evidence have indicated that chronic infection with hepatitis C virus (HCV) poses a major risk towards the development of hepatocellular carcinoma (HCC). It remains controversial whether HCV plays a direct role in the pathogenesis of HCV-associated HCC or whether it merely serves an indirect role. Using the transgenic mouse model established by us, it has become evident that the core protein of HCV confers oncogenic potential. The findings in our studies indicate that HCV is directly involved in hepatocarcinogenesis, albeit other factors, such as continued cell death and regeneration associated with chronic hepatitis, may also play a role. Taken together, our results indicate that there could be a mechanism for the development of HCC in persistent hepatitis virus infection that is distinct from the pathogenesis of other cancers, like colorectal cancer. Thus, although accumulation of a set of genetic aberrations may also be necessary for a multistage development of HCC, HCV core protein, to which an oncogenic potential is ascribed, may allow some stages to be skipped in hepatocarcinogenesis. The possibility that infection with HCV may be capable of inducing HCC in the absence of a complete set of genetic aberrations would help explain the unusually high incidence and multicentric nature of HCC developing in chronic hepatitis C. Copyright 2002 Blackwell Publishing Asia Pty Ltd

Entities:  

Mesh:

Year:  2002        PMID: 11982718     DOI: 10.1046/j.1440-1746.2002.02763.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  9 in total

1.  Tumor-promoting/progressing role of additional chromosome instability in hepatic carcinogenesis in Sgo1 (Shugoshin 1) haploinsufficient mice.

Authors:  Hiroshi Y Yamada; Yuting Zhang; Arun Reddy; Altaf Mohammed; Stan Lightfoot; Wei Dai; Chinthalapally V Rao
Journal:  Carcinogenesis       Date:  2015-03-04       Impact factor: 4.944

Review 2.  Hepatocellular carcinoma: insight from animal models.

Authors:  Yan Li; Zhao-You Tang; Jin-Xuan Hou
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-10-25       Impact factor: 46.802

3.  Clonality analysis for multicentric origin and intrahepatic metastasis in recurrent and primary hepatocellular carcinoma.

Authors:  Qiang Li; Jian Wang; Jonathan T Juzi; Yan Sun; Hong Zheng; Yunlong Cui; Haixin Li; Xishan Hao
Journal:  J Gastrointest Surg       Date:  2008-07-16       Impact factor: 3.452

Review 4.  Experimental models of hepatocellular carcinoma: developments and evolution.

Authors:  Long Wu; Zhao-You Tang; Yan Li
Journal:  J Cancer Res Clin Oncol       Date:  2009-04-28       Impact factor: 4.553

Review 5.  Experimental models of hepatocellular carcinoma.

Authors:  Philippa Newell; Augusto Villanueva; Scott L Friedman; Kazuhiko Koike; Josep M Llovet
Journal:  J Hepatol       Date:  2008-01-30       Impact factor: 25.083

6.  Molecular signatures associated with HCV-induced hepatocellular carcinoma and liver metastasis.

Authors:  Valeria De Giorgi; Luigi Buonaguro; Andrea Worschech; Maria Lina Tornesello; Francesco Izzo; Francesco M Marincola; Ena Wang; Franco M Buonaguro
Journal:  PLoS One       Date:  2013-02-18       Impact factor: 3.240

Review 7.  Mouse models for the study of HCV infection and virus-host interactions.

Authors:  Heidi Barth; Eric Robinet; T Jake Liang; Thomas F Baumert
Journal:  J Hepatol       Date:  2008-04-14       Impact factor: 25.083

8.  Identification and functional analysis of a core gene module associated with hepatitis C virus-induced human hepatocellular carcinoma progression.

Authors:  Gaobo Bai; Wenling Zheng; Wenli Ma
Journal:  Oncol Lett       Date:  2018-03-09       Impact factor: 2.967

Review 9.  Animal Models Used in Hepatitis C Virus Research.

Authors:  Keith A Berggren; Saori Suzuki; Alexander Ploss
Journal:  Int J Mol Sci       Date:  2020-05-29       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.